Related Sadava s chapters: 1) From DNA to protein

Transcription

1 8.0 Gene expression and mutation Related Sadava s chapters: 1) From DNA to protein 2) Gene mutation

2 What Is the Evidence that Genes Code for Proteins? How Does Information Flow from Genes to Proteins?

3 Identification of a gene product as a protein began with a mutation. Garrod saw a disease phenotype alkaptonuria occurring in children who shared more alleles as first cousins. A substance in their blood (HA, homogentisic acid) accumulated was not catalyzed the gene for the enzyme was mutated. Garrod correlated one gene to one enzyme.

4 Beadle and Tatum used Neurospora to test hypothesis that specific gene expression specific enzyme activity. Neurospora is haploid for most of its life cycle all alleles are expressed as phenotypes. Wild-type strains like Neurospora are prototrophs have enzymes to catalyze all reactions to make cell constituents. Beadle and Tatum used X rays as mutagens to cause mutations inherited genotypic changes. Mutants were auxotrophs needed additional nutrients to grow. For each auxotrophic mutant strain, the addition of just one compound supported growth. Results suggested that each mutation caused a defect in only one enzyme in a metabolic pathway.

5

6 The gene-enzyme relationship has since been revised to the one-gene, onepolypeptide relationship. Example: In hemoglobin, each polypeptide chain is specified by a separate gene. Other genes code for RNA are not translated to polypeptides; some genes are involved in controlling other genes.

7 Gene expression to form a specific polypeptide occurs in two steps: Transcription copies information from a DNA sequence (a gene) to a complementary RNA sequence Translation converts RNA sequence to amino acid sequence of a polypeptide The central dogma of molecular biology.

8 RNA (ribonucleic acid) differs from DNA: Usually one polynucleotide strand The sugar is ribose Contains uracil (U) instead of thymine (T)

9 Bases in RNA can pair with a single strand of DNA, except that adenine pairs with uracil instead of thymine. Single-strand RNA can fold into complex shapes by internal base pairing.

10 Three kinds of RNA in protein synthesis: Messenger RNA (mrna) carries copy of a DNA sequence to site of protein synthesis at the ribosome Transfer RNA (trna) carries amino acids for polypeptide assembly Ribosomal RNA (rrna) catalyzes peptide bonds and provides structure

11 The central dogma suggested that information flows from DNA to RNA to protein, which raised two questions: How does genetic information get from the nucleus to the cytoplasm? What is the relationship between a DNA sequence and an amino acid sequence?

12

13 Exception to the central dogma: Viruses: Non-cellular particles that reproduce inside cells; many have RNA instead of DNA. Viruses can replicate by transcribing from RNA to RNA, and then making multiple copies by transcription.

14

15 RNA polymerases catalyze synthesis of RNA. RNA polymerases are processive a single enzyme-template binding results in polymerization of hundreds of RNA bases. Unlike DNA polymerases, RNA polymerases do not need primers and lack a proofreading function.

16

17

18 The genetic code: Specifies which amino acids will be used to build a protein Codon: A sequence of three bases each codon specifies a particular amino acid. Start codon: AUG initiation signal for translation. Stop codons: UAA, UAG, UGA stop translation and polypeptide is released.

19

20

21 For most amino acids, there is more than one codon; the genetic code is redundant. Wobble base pair The genetic code is not ambiguous each codon specifies only one amino acid. The genetic code is nearly universal: The codons that specify amino acids are the same in all organisms. Exceptions: within mitochondria and chloroplasts, and in one group of protists, there are differences. The frequency of synonymous codons varies between species. Three reading frames coexist on the DNA/RNA coding sequence.

22 Prokaryotes and eukaryotes differ in gene structure in the organization of nucleotide sequences. In eukaryotes a nucleus separates transcription and translation. Eukaryotic genes may have noncoding sequences introns. The coding sequences are exons. Introns and exons appear in the primary mrna transcript premrna; introns are removed from the final mrna.

23 Figure 14.7 Transcription of a Eukaryotic Gene (1) 8.1 From DNA to protein: gene expression

24

25

26 Introns interrupt, but do not scramble, the DNA sequence that encodes a polypeptide. Sometimes, the separated exons code for different domains (functional regions) of the protein.

27

28 e2 e1 e3 e1 e3 e1 e2 e3 e2 e1 e3 e4 e1 e2 e3 e1 e2 e4 Lipscombe, Current Opinion in Neurobiology

29 WT1 24 isoforms CD isoforms DSCAM isoforms!!! Roberts & Smith (2002)

30 In the disease β-thalassemia, a mutation may occur at an intron consensus sequence in the β-globin gene the pre-mrna can not be spliced correctly. Non-functional β-globin mrna is produced.

31

32 Mature mrna leaves the nucleus through nuclear pores. TAP protein binds to the 5 end; this binds to other proteins that are recognized by receptors at the nuclear pore. These proteins lead the mrna through the pore unused pre-mrnas stay in the nucleus.

33

34 trna, the adapter molecule, links information in mrna codons with specific amino acids. For each amino acid, there is a specific type or species of trna. Three functions of trna: It binds to an amino acid, and is then charged It associates with mrna molecules It interacts with ribosomes

35

36 Wobble: Specificity for the base at the 3 end of the codon is not always observed. Example: Codons for alanine GCA, GCC, and GCU are recognized by the same trna. Wobble allows cells to produce fewer trna species, but does not allow the genetic code to be ambiguous.

37 Activating enzymes aminoacyl-trna synthetases charge trna with the correct amino acids. Each enzyme is highly specific for one amino acid and its corresponding trna; the process of trna charging is called the second genetic code. The enzymes have three-part active sites: They bind a specific amino acid, a specific trna, and ATP.

38

39 Experiment by Benzer and others: Cysteine already bound to trna was chemically changed to alanine. Which would be recognized the amino acid or the trna in protein synthesis? Answer: Protein synthesis machinery recognizes the anticodon, not the amino acid.

40 Ribosome: the workbench holds mrna and charged trnas in the correct positions to allow assembly of polypeptide chain. Ribosomes are not specific, they can make any type of protein. Ribosomes have two subunits, large and small. In eukaryotes, the large subunit has three molecules of ribosomal RNA (rrna) and 49 different proteins in a precise pattern. The small subunit has one rrna and 33 proteins.

41

42

43

44

45 Figure The Termination of Translation (Part 1)

46 Figure The Termination of Translation (Part 2)

47 Figure The Termination of Translation (Part 3)

48 The large subunit has peptidyl transferase activity if rrna is destroyed, the activity stops Therefore rrna is the catalyst in peptidyl transferase activity. This supports the idea that catalytic RNA evolved before DNA.

49

50 Several ribosomes can work together to translate the same mrna, producing multiple copies of the polypeptide. A strand of mrna with associated ribosomes is called a polyribosome, or polysome.

51 Figure A Polysome (A)

52 Figure A Polysome (B) 8.1 From DNA to protein: gene expression

53 Posttranslational aspects of protein synthesis: Polypeptide emerges from the ribosome and folds into its 3-D shape. Its conformation allows it to interact with other molecules it may contain a signal sequence indicating where in the cell it belongs.

54

55

56 Figure A Signal Sequence Moves a Polypeptide into the ER (1) 8.1 From DNA to protein: gene expression

57 14.6 What Happens to Polypeptides after Translation? If finished protein enters ER lumen, it receives signals of two types: Sequences of amino acids allow protein to stay in ER Sugars are added glycoproteins end up at the plasma membrane, lysosome, (vacuole in plants), or are secreted

58 14.6 What Happens to Polypeptides after Translation? Protein modifications: Proteolysis: Cutting of a long polypeptide chain into final products, by proteases Glycosylation: Addition of sugars to form glycoproteins Phosphorylation: Addition of phosphate groups catalyzed by protein kinases charged phosphate groups change the conformation

59 15.1 What Are Mutations? Genetic mutations are changes in the nucleotide sequences of DNA that are passed on to the next generation. Mutations may or may not have a phenotypic effect.

60 15.1 What Are Mutations? Mutations occur in two types: Somatic mutations occur in somatic (body) cells passed on by mitosis but not to sexually produced offspring Germ line mutations occur in germ line cells, the cells that give rise to gametes. A gamete passes a mutation on at fertilization

61 15.1 What Are Mutations? Mutations have different phenotypic effects: Silent mutations do not affect protein function Loss of function mutations affect protein function and may lead to structural proteins or enzymes that no longer work almost always recessive

62 15.1 What Are Mutations? Mutations have different phenotypic effects: Gain of function mutations lead to a protein with altered function Conditional mutations cause phenotypes under restrictive conditions but are not detectable under permissive conditions

63 15.1 What Are Mutations? At the molecular level, mutations or alterations in the nucleotide sequence are in two categories: A point mutation results from the gain, loss, or substitution of a single nucleotide Chromosomal mutations are more extensive may change the position or cause a DNA segment to be duplicated or lost

64

65 8.2 Gene mutation and molecular medicine Mutations occur in two types: Somatic mutations occur in somatic (body) cells passed on by mitosis but not to sexually produced offspring Germ line mutations occur in germ line cells, the cells that give rise to gametes. A gamete passes a mutation on at fertilization

66 8.2 Gene mutation and molecular medicine

67 8.2 Gene mutation and molecular medicine

68 Figure 15.4 Chromosomal Mutations (A,B) 8.2 Gene mutation and molecular medicine

69 Figure 15.5 Spontaneous and Induced Mutations (B,C) 8.2 Gene mutation and molecular medicine

70 8.2 Gene mutation and molecular medicine

71 8.2 Gene mutation and molecular medicine New methods of human genetic analysis include reverse genetics. A clinical phenotype is related to a DNA variation then the protein is identified. Previously, as in sickle-cell anemia: Clinical phenotype protein phenotype gene

72 8.2 Gene mutation and molecular medicine Mutations may have benefits: Provide the raw material for evolution in the form of genetic diversity Diversity may benefit the organism immediately if mutation is in somatic cells Or may cause an advantageous change in offspring

73 8.2 Gene mutation and molecular medicine Most human diseases are multifactorial caused by interactions of many genes and proteins and the environment. Susceptibility to disease is determined by these complex interactions. 60 percent of people are affected by diseases that are genetically influenced.

74 8.2 Gene mutation and molecular medicine DNA testing is direct analysis of DNA for mutation; the most accurate way of detecting an abnormal allele. Preimplantation screening of a zygote can be used for parents of a child with a disease like cystic fibrosis. Fetal cells and newborns can be tested for sickle-cell disease and others.

75 8.2 Gene mutation and molecular medicine Two main approaches to treating genetic diseases: Modifying the disease phenotype Replacing the defective gene

76 8.2 Gene mutation and molecular medicine Modifying the disease phenotype can be done in three ways: Restricting the substrate as in PKU, reducing phenylalanine in the diet Metabolic inhibitors, such as drugs that can target specific proteins Supplying the missing protein blood factor VIII in hemophilia

77 8.2 Gene mutation and molecular medicine In gene therapy, the aim is to supply the missing allele(s) by inserting a new gene that will be expressed in the host. The challenges: Must find appropriate vector, ensure precise insertion into host DNA, ensure appropriate expression, and select cells to target. The nonfunctional alleles cannot be replaced in every cell of the body. Ex vivo techniques cells are removed from the body, new genes inserted in the laboratory, cells returned to the body so that correct gene products are made.